Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
about
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenzaPlant-based vaccines for animals and humans: recent advances in technology and clinical trialsPlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsVirus-like particles as antigenic nanomaterials for inducing protective immune responses in the lungH5N1 vaccines in humansWhen plant virology met Agrobacterium: the rise of the deconstructed clonesPreclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominanceAn interspecific Nicotiana hybrid as a useful and cost-effective platform for production of animal vaccinesSingle-dose monomeric HA subunit vaccine generates full protection from influenza challenge.Plant virus expression vector development: new perspectives.Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection.Influenza vaccines: a moving interdisciplinary field.Immunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.Hydrophobin fusion of an influenza virus hemagglutinin allows high transient expression in Nicotiana benthamiana, easy purification and immune response with neutralizing activity.Early vaccine availability represents an important public health advance for the control of pandemic influenza.Using plant cells as influenza vaccine substrates.Influenza vaccines based on virus-like particlesSwine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccinesAdvances in novel influenza vaccines: a patent review.Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud.Plant-made vaccines in support of the Millennium Development Goals.New technologies for influenza vaccines.Setting up a platform for plant-based influenza virus vaccine production in South Africa.The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.Vaccine development for protecting swine against influenza virus.A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesHealth systems' "surge capacity": state of the art and priorities for future researchUsing a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza UncertaintyInfluence of elastin-like polypeptide and hydrophobin on recombinant hemagglutinin accumulations in transgenic tobacco plants.Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection.Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthPlant-based vaccines against viruses.Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosisMice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virusProduction of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine.Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.Plant-derived virus-like particles as vaccines
P2860
Q21091074-D9BDC167-66AD-4629-81C1-4A1D25584645Q26775788-6BB48476-FCE5-4C9B-B0E9-16F6BC62517BQ26783107-6FE01735-4DCD-4E2C-A648-75EBD1225DD0Q26825031-A37EBB3C-13F6-40D4-B3D2-8809A94F875CQ27000896-759A03B2-88B5-4AF2-9FB4-14BAE2436D22Q28083891-C786B971-F90C-479B-B3C8-9B5942A89175Q28247277-18AB1BC2-21EB-4E4E-A753-1B909856E5A5Q28728106-839A1611-CA9E-4300-8843-17A7E21E3CF4Q28730453-079BDEC9-BBA5-4C4E-A319-9584EDEA7A17Q30357409-344E329B-EE81-40CC-B45D-D105F2A55BC7Q30361514-E7AD175E-9B6C-4CD0-9D27-DCD43D0A18B7Q30365159-A633C8DC-9EF5-480D-A511-44E67B8DD712Q30367695-551C3C6E-BCFF-490E-99B0-8716CCB9C63BQ30369470-09673E20-86CB-4FCD-AA2E-B71F507D90C0Q30370156-399100C5-0B88-4472-A6E5-6AF799E56108Q30374481-DB1AF69C-3963-46F8-8795-A3D28E73613EQ30375988-DC10F177-5CD6-4357-B02F-27736E47B33BQ30376236-A72E8666-C64B-4DAD-BBDD-4A464BDE205EQ30383973-2AAEE09C-D5B3-42F9-AB85-498847CB562FQ30387030-2A1C11F3-5E22-4FDA-BFC9-8EA7DCFAD0FCQ30388514-9187E306-5A3C-4EF5-9D23-E1CDAD1286FAQ30395281-87F5569D-758B-457A-A011-D356CC072FACQ30396217-5367D7F5-C02C-4A79-BA69-40A0D1C4F7D3Q30411859-6F22B1C5-5B36-4196-B9CE-DD34F5025BA7Q30416072-F6430F40-3CC7-49C9-A0C4-A883C327C9E8Q30417273-89EEF738-1540-42EA-ACF0-F94480A21C48Q30424943-5EFAC6C8-04F6-45BE-8E43-693BA454143EQ30425590-537BF645-5EE0-400E-A824-5001F26B2310Q30427591-7AC143AC-9185-4908-B46E-0B280C09D32FQ30428206-2741E574-58D6-414B-9C5C-2EA092F1BB27Q30432474-5D872B15-D363-4D41-B818-F4A20A5202A0Q31165032-32C4E877-40D6-423F-BBAC-0457E37E763FQ34296139-26DC249D-48FF-4FB7-B158-685EAF96B181Q34497705-47A2CFDA-173F-48B2-ABE9-F3BBC58B1881Q34687464-FBEFDC41-427B-4AD9-88A1-8F53FA32EF82Q35300720-7B62327B-DDEF-41DF-8DCD-0216374526D5Q35598223-B31D1423-B3EA-466C-870E-5088AD31313AQ36352851-454DE1CF-98C5-46D7-930C-8B9B9F1373B1Q36849574-E90A8B28-00D4-46DE-A8F6-79E1FFD50A8FQ36888029-E2284D5B-1FB7-4488-BFA0-418673265E2B
P2860
Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Influenza virus-like particles ...... ethal viral challenge in mice.
@ast
Influenza virus-like particles ...... ethal viral challenge in mice.
@en
type
label
Influenza virus-like particles ...... ethal viral challenge in mice.
@ast
Influenza virus-like particles ...... ethal viral challenge in mice.
@en
prefLabel
Influenza virus-like particles ...... ethal viral challenge in mice.
@ast
Influenza virus-like particles ...... ethal viral challenge in mice.
@en
P2093
P1476
Influenza virus-like particles ...... ethal viral challenge in mice.
@en
P2093
Brian J Ward
Jean-Martin Guay
Louis-P Vézina
Manon M-J Couture
Marc-André D'Aoust
Michèle Dargis
Nathalie Landry
Pierre-Olivier Lavoie
Sonia Trépanier
Sébastien Mongrand
P304
P356
10.1111/J.1467-7652.2008.00384.X
P577
2008-12-01T00:00:00Z